OBJECTIVE: The limitations of PAP smears in diagnosing severe cervical glandular lesions motivate the development of ancillary methods to facilitate their detection. This prospective cytology-histology and molecular study aims to investigate methylation test performance by establishing the test sensitivity and its relevance to patient management. METHOD: LBC samples were prospectively acquired after 3 months following the primary conventional PAP-smear screening diagnosis of AGC-NEO (atypical glandular cells, favour neoplastic) and AIS. An HPV test and methylation test were performed. Corresponding subsequent biopsy reports were collected. RESULTS: Seven hundred and seventy Pap tests were signed out as AGC-NEO+. Complete study data were available for 85 cases (AIS in 46 cases, EA in 39 cases) that were further analysed. The methylation test was positive in 95.3% (81/85) cases, negative in 3.5% (3/85, AIS in two cases, EA in one case) and unanalysable in one sample (1.2%). HPV genotyping revealed a multi-infection rate of 29%. The presence of HPV types 16 and 18 was detected in 84% (72/85) of lesions, and HPV type 45 in 12% (10/85). CONCLUSIONS: The methylation test shows a high sensitivity of 95.3% and reliably identifies histologically confirmed AIS+ lesions. This argues for further investigation into its performance characteristics and consideration of its use, especially as a pre-surgical triaging test in sensitive cases if the AIS+ lesion is suspected in pregnant women or nullipara.

Bioptická laboratoř s r o Pilsen Czech Republic

Charles University and Charles University Hospital Pilsen Department of Gynecology and Obstetrics Medical Faculty Pilsen Czech Republic

Charles University and Charles University Hospital Pilsen Department of Pathology Medical Faculty Pilsen Czech Republic

Zobrazit více v PubMed

Wilbur D. C., Chhieng D. C., Guidos B., et al., “Epithelial Cell Abnormalities: Glandular,” in The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria and Explanatory Notes, 3rd ed., ed. Nayar R. and Wilbur D. C. (Springer, 2015), 194.

Lee K. R., Darragh T. M., Joste N. E., et al., “Atypical Glandular Cells of Undetermined Significance (AGUS): Interobserver Reproducibility in Cervical Smears and Corresponding Thin–Layer Preparations,” American Journal of Clinical Pathology 117 (2002): 96–102. PubMed

Moriarty A. T. and Wilbur D., “Those Gland Problems in Cervical Cytology: Faith or Fact? Observations From the Bethesda 2001 Terminology Conference,” Diagnostic Cytopathology 28 (2003): 171–174. PubMed

Ozkan F., Ramzy I., and Mody D. R., “Glandular Lesions of the Cervix on Thin–Layer Pap Tests. Validity of Cytologic Criteria Used in Identifying Significant Lesions,” Acta Cytologica 48 (2004): 372–379. PubMed

Wood M. D., Horst J. A., and Bibbo M., “Weeding Atypical Glandular Cell Look‐Alikes From the True Atypical Lesions in Liquid–Based Pap Tests: A Review,” Diagnostic Cytopathology 35 (2007): 12–17. PubMed

Conrad R. D., Liu A. H., Wentzensen N., et al., “Cytologic Patterns of Cervical Adenocarcinomas With Emphasis on Factors Associated With Underdiagnosis,” Cancer Cytopathology 126 (2018): 950–958. PubMed PMC

Leeson S. C., Alibegashvili T., Arbyn M., et al., “HPV Testing and Vaccination in Europe,” Journal of Lower Genital Tract Disease 18 (2014): 61–69. PubMed

de Sanjose S., Quint W. G., Alemany L., et al., “Human Papillomavirus Genotype Attribution in Invasive Cervical Cancer: A Retrospective Cross‐Sectional Worldwide Study,” Lancet Oncology 11 (2010): 1048–1056. PubMed

Miller R. A., Mody D. R., Tams K. C., and Thrall M. J., “Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions,” Archives of Pathology & Laboratory Medicine 139 (2015): 1431–1436. PubMed

Cleveland A. A., Gargano J. W., Park I. U., et al., “Cervical Adenocarcinoma In Situ: Human Papillomavirus Types and Incidence Trends in Five States, 2008–2015,” International Journal of Cancer 146, no. 3 (2020): 810–818, 10.1002/ijc.32340. PubMed DOI PMC

Herman J. G. and Baylin S. B., “Gene Silencing in Cancer in Association With Promoter Hypermethylation,” New England Journal of Medicine 349, no. 21 (2003): 2042–2054, 10.1056/NEJMra023075. PubMed DOI

Vink F. J., Meijer C. J. L. M., Clifford G. M., et al., “FAM19A4/miR124‐2 Methylation in Invasive Cervical Cancer: A Retrospective Cross–Sectional Worldwide Study,” International Journal of Cancer 147, no. 4 (2020): 1215–1221, 10.1002/ijc.32614. PubMed DOI PMC

Tieben L. M., ter Schegget J., Minnaar R. P., et al., “Detection of Cutaneous and Genital HPV Types in Clinical Samples by PCR Using Consensus Primers,” Journal of Virological Methods 42 (1993): 265–279. PubMed

Karlsen F., Kalantari M., Jenkins A., et al., “Use of Multiple PCR Primer Sets for Optimal Detection of Human Papillomavirus,” Journal of Clinical Microbiology 34 (1996): 2095–2100. PubMed PMC

Holl K., Nowakowski A. M., Powell N., et al., “Human Papillomavirus Prevalence and Type‐Distribution in Cervical Glandular Neoplasias: Results From a European Multinational Epidemiological Study,” International Journal of Cancer 137, no. 12 (2015): 2858–2868, 10.1002/ijc.29651. PubMed DOI PMC

Qin Y., Deng J., Ling Y., Chen T., and Gao H., “Our Experience Diagnosing 225 Patients With Cervical Glandular Lesions: Current Technologies, Lessons Learned, and Areas for Improvement,” Diagnostic Pathology 19, no. 1 (2024): 22, 10.1186/s13000-023-01428-3. PubMed DOI PMC

Niu S., Molberg K., Thibodeaux J., et al., “Challenges in the Pap Diagnosis of Endocervical Adenocarcinoma In Situ,” Journal of the American Society of Cytopathology 8 (2019): 141–148. PubMed

Lindroth Y., Pedersen L., Alssamaray J., et al., “Cervix Cytology Samples Revealed Increased Methylation of the Human Markers FAM19A4/miR124‐2 up to 8 Years Before Adenocarcinoma,” Acta Obstetricia et Gynecologica Scandinavica 103 (2024): 378–386, 10.1111/aogs.14707. PubMed DOI PMC

Ondič O., Němcová J., Alaghehbandan R., et al., “The Detection of DNA Methylation of Tumour Suppressor Genes in Cervical High–Grade Squamous Intraepithelial Lesion: A Prospective Cytological–Histological Correlation Study of 70 Cases,” Cytopathology 30, no. 4 (2019): 426–431, 10.1111/cyt.12718. PubMed DOI

De Strooper L. M. A., Berkhof J., Steenbergen R. D. M., et al., “Cervical Cancer Risk in HPV‐Positive Women After a Negative FAM19A4/mir124‐2 Methylation Test: A Post Hoc Analysis in the POBASCAM Trial With 14 Year Follow‐Up,” International Journal of Cancer 143 (2018): 1541–1548. PubMed PMC

Zummeren M. V., Kremer W. W., Leeman A., et al., “HPV E4 Expression and DNA Hypermethylation of CADM1, MAL, and miR124‐2 Genes in Cervical Cancer and Precursor Lesions,” Modern Pathology 31, no. 12 (2018): 1842–1850, 10.1038/s41379-018-0101-z. PubMed DOI

Herting W., Genz H. J., Tauber P. F., and Ludwig H., “Ekto– Und Endozervikale Zellveränderungen Im Abstrich Von cu–IUD–Trägerinnen [Ecto– And Endocervical Cell Changes in Vaginal Smears From Copper IUD Carriers],” Archives of Gynecology 228, no. 1–4 (1979): 640–641. German, 10.1007/BF02427530. PubMed DOI

Bariş I. İ. and Keleş A. N., “Mardin Bölgesinden Verilerle Servikal Sitolojide RIA Etkisine Bir Bakış [A Review on the Impact of IUD in Cervical Cytology: Mardin Region Data],” Turk Patoloji Derg 29, no. 1 (2013): 51–57. Turkish, 10.5146/tjpath.2013.01148. PubMed DOI

Young R. H. and Clement P. B., “Pseudoneoplastic Glandular Lesions of the Uterine Cervix,” Seminars in Diagnostic Pathology 8, no. 4 (1991): 234–249. PubMed

McCluggage G., McBride H., Maxwell P., and Bharucha H., “Immunohistochemical Detection of p53 and Bcl‐2 Proteins in Neoplastic and Non‐Neoplastic Endocervical Glandular Lesions,” International Journal of Gynecological Pathology 16, no. 1 (1997): 22–27, 10.1097/00004347–199701000–00004. PubMed DOI

Nucci M. R., “Symposium Part III: Tumor‐Like Glandular Lesions of the Uterine Cervix,” International Journal of Gynecological Pathology 21, no. 4 (2002): 347–359, 10.1097/00004347–200210000–00004. PubMed DOI

Rabban J. T., McAlhany S., Lerwill M. F., Grenert J. P., and Zaloudek C. J., “PAX2 Distinguishes Benign Mesonephric and Mullerian Glandular Lesions of the Cervix From Endocervical Adenocarcinoma, Including Minimal Deviation Adenocarcinoma,” American Journal of Surgical Pathology 34, no. 2 (2010): 137–146, 10.1097/PAS.0b013e3181c89c98. PubMed DOI

Stolnicu S. and McCluggage W. G., “The Evolving Spectrum of Endocervical Adenocarcinoma In Situ (AIS),” Virchows Archiv 476, no. 4 (2020): 485–486, 10.1007/s00428-020-02770-3. PubMed DOI

Stolnicu S., Talia K. L., and McCluggage W. G., “The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas,” Advances in Anatomic Pathology 27, no. 5 (2020): 278–293, 10.1097/PAP.0000000000000266. PubMed DOI

Crum P., Hoang L. N., Parra–Herran C., et al., “Adenocarcinoma In Situ, HPV‐Associated, of the Uterine Cervix,” in WHO Classification of Tumours Editorial Board. Female Genital Tumours [Internet] (International Agency for Research on Cancer, 2020), [cited 2024 Dec 31]. (WHO classification of tumours series, 5th ed.; vol. 4), https://https://tumourclassification.iarc.who.int/chaptercontent/34/496.

Cibula D., Raspollini M. R., Planchamp F., et al., “ESGO/ESTRO/ESP Guidelines for the Management of Patients With Cervical Cancer – Update 2023*,” Virchows Archiv 482 (2023): 935–966, 10.1007/s00428-023-03552-3. PubMed DOI PMC

Diaz J. P., Sonoda Y., Leitao M. M., et al., “Oncologic Outcome of Fertility‐Sparing Radical Trachelectomy Versus Radical Hysterectomy for Stage IB1 Cervical Carcinoma,” Gynecologic Oncology 111, no. 2 (2008): 255–260, 10.1016/j.ygyno.2008.07.014. PubMed DOI

Plante M., Gregoire J., Renaud M. C., and Roy M., “The Vaginal Radical Trachelectomy: An Update of a Series of 125 Cases and 106 Pregnancies,” Gynecologic Oncology 121, no. 2 (2011): 290–297, 10.1016/j.ygyno.2010.12.345. PubMed DOI

Robova H., Rob L., Halaska M. J., et al., “Twenty Years of Experience With Less Radical Fertility‐Sparing Surgery in Early‐Stage Cervical Cancer: Pregnancy Outcomes,” Gynecologic Oncology 174 (2023): 76–79, 10.1016/j.ygyno.2023.04.016. PubMed DOI